| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/10/2007 | EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740574A2 4-amino-5-cyanopyrimidine derivatives |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740563A2 Mycophenolate mofetil impurity |
| 01/10/2007 | EP1740559A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/10/2007 | EP1740558A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors |
| 01/10/2007 | EP1740556A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 01/10/2007 | EP1740549A2 Novel imidazoles |
| 01/10/2007 | EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors |
| 01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
| 01/10/2007 | EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/10/2007 | EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 01/10/2007 | CN1894243A 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 01/10/2007 | CN1894242A Novel oxazolidinone derivatives |
| 01/10/2007 | CN1894241A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 01/10/2007 | CN1894240A 阿片受体拮抗剂 Opioid receptor antagonist |
| 01/10/2007 | CN1894237A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 01/10/2007 | CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 01/10/2007 | CN1894225A (3,4-disubstituted)propanoic carboxylates as SLP (EDG) receptor agonists |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/10/2007 | CN1893825A Substituted arylpyrazoles as parasiticidal agents |
| 01/10/2007 | CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine |
| 01/10/2007 | CN1294130C Substituted pyrazoles |
| 01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
| 01/09/2007 | US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 01/09/2007 | US7160915 N-methyl-substituted benzamidazoles |
| 01/09/2007 | US7160912 Oxazolidinone derivative of the formula (I) or a salt thereof, or a stereoisomer thereof, where R1 represents NHR4 wherein R4 represents thio(C1-C10)acyl, C( . dbd. S)-cyclo(C3-C8)alkoxy, C( .dbd. S) (C1-C10)alkoxy, C( .dbd.S |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160901 Antiproliferative agents; antitumor agents; kinase inhibitors |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 01/09/2007 | US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction |
| 01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/09/2007 | US7160882 Long acting β-2-agonists and their use as medicaments |
| 01/09/2007 | US7160877 Aliphatic nitrogen-containing 5-membered ring compound |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2338276C Fkbp inhibitors |
| 01/09/2007 | CA2223011C Oxazolidinone derivatives, their preparation and therapeutical use |
| 01/04/2007 | WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001225A1 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators. |
| 01/04/2007 | WO2007000644A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | WO2007000582A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | WO2006093911A3 Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives |
| 01/04/2007 | WO2006041872A3 Thrombin receptor antagonists |
| 01/04/2007 | WO2006020598A3 Amido compounds and their use as pharmaceuticals |
| 01/04/2007 | WO2006010142A3 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004786 (5S)-2-Amino-5-(1-ethyl-5-propionyl-1H-pyrrol-3-yl)-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-3,5-dihydro-4H-imidazol-4-one; to treat Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits |
| 01/04/2007 | US20070004769 For a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker |
| 01/04/2007 | US20070004752 serotonin, dopamin,muscarinic acetocholin, adrenergic receptors modulator; insomnia, hypersomnia, narcolepsy, sleep apnea syndrome, parasomnia, restless leg syndrome, and circadian rhythm abnormality; side effect reduction |
| 01/04/2007 | US20070004751 Substituted heterocyclic compounds |
| 01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
| 01/04/2007 | US20070004723 To inhibit replication and/or proliferation of Hepatitis C virus; viral infections; 5-Dichloromethyl-3-[4-[3'-(2',6'-dichlorophenyl)-5'-isoxazolyl]phenyl]-1,2,4-oxadiazole |
| 01/04/2007 | US20070004719 Inhibitors of cytosolic phospholipase A2 |
| 01/04/2007 | US20070004717 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(-4-hydroxy-1-oxo-hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-methylbenzonitrile |
| 01/04/2007 | US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004712 Salts of novel heterocyclic compounds having antibacterial activity |
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X |
| 01/04/2007 | US20070004682 diamino-substituted 1,2,5-oxadiazoles for treatment of cancer, gingivitis, antiatherosclerosis, as viricide, aniinflammatory agent, antiogenesis inhibitor and analgesic |
| 01/04/2007 | US20070004642 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 01/04/2007 | CA2613162A1 Heterocyclic non-peptide gnrh antagonists |
| 01/04/2007 | CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 01/04/2007 | CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | CA2611128A1 Novel indoline compounds |
| 01/04/2007 | CA2610978A1 Homomorpholine oxazolidinones as antibacterial agents |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/03/2007 | EP1739086A2 Pharmaceutical compositions of risperidone in aqueous solution |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1737851A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents) |
| 01/03/2007 | EP1737850A2 A novel process for the preparation of linezolid and related compounds |
| 01/03/2007 | EP1737849A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 inhibitors |
| 01/03/2007 | EP1737846A1 New process for the preparation of diazine derivatives |
| 01/03/2007 | EP1737845A2 Disalt inhibitors of il-12 production |
| 01/03/2007 | EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides |
| 01/03/2007 | EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 01/03/2007 | EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737451A2 Monocyclic heterocycles as kinase inhibitors |